메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
윤호중 (가톨릭대학교)
저널정보
대한종양외과학회 KOREAN JOURNAL OF CLINICAL ONCOLOGY Korean Journal of Clinical Oncology 제5권 제1호
발행연도
2009.6
수록면
9 - 14 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Chemotherapy induced cardiotoxicity is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and may cause severe morbidity in surviving cancer patients. The mechanism of anthracycline induced cardiotoxicity, relatively well established, seems to involve the free radicals formation and the apoptosis of myocytes. Prevention of cardiac toxicity can be achieved by control of the cumulative dose. Furthermore, addition of the iron chelator to anthracycline therapy has shown to be helpful. Other cytotoxic drugs such as the taxoids, 5-fluorouracil, cyclophosphamide and trastuzumab are associated with cardiotoxicity as well, although little is known about the possible mechanisms. The pathophysiology of these adverse effects is similarly heterogeneous and the identification of potential mechanisms is frequently difficult since the majority of cancer patients is not only treated with multiple anti-cancer drugs but might also be exposed to potentially cardiotoxic radiation therapy. Further research is warranted to understand the mechanism of chemotherapy induced cardiotoxicity and to develop strategies to avoid this side effect.

목차

서론
결론
REFERENCES
Abstract

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2014-513-001300488